Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.

CONTEXT The epidemiology of primary hyperparathyroidism (PHPT) has generally been studied in Caucasian populations. OBJECTIVE The aim was to examine the incidence and prevalence of PHPT within a racially mixed population. DESIGN A descriptive epidemiologic study was performed. PATIENTS/SETTING The study population included 3.5 million enrollees within Kaiser Permanente Southern California. METHODS All patients with at least one elevated serum calcium level (>10.5 mg/dL, 2.6 mmol/L) between 1995 and 2010 were included. Cases of PHPT were identified by electronic query of laboratory values using biochemical criteria, after exclusion of secondary or renal and tertiary hyperparathyroidism cases. The incidence and prevalence rates of PHPT were calculated according to sex, race, age group by decade, and year. RESULTS Initial case finding identified 15,234 patients with chronic hypercalcemia, 13,327 (87%) of which had PHPT as defined by elevated or inappropriately normal parathyroid hormone levels. The incidence of PHPT fluctuated from 34 to 120 per 100,000 person-years (mean 66) among women, and from 13 to 36 (mean 25) among men. With advancing age, incidence increased and sex differences became pronounced (incidence 12-24 per 100,000 for both sexes younger than 50 y; 80 and 36 per 100,000 for women and men aged 50-59 y, respectively; and 196 and 95 for women and men aged 70-79 y, respectively). The incidence of PHPT was highest among blacks (92 women; 46 men, P < .0001), followed by whites (81 women; 29 men), with rates for Asians (52 women, 28 men), Hispanics (49 women, 17 men), and other races (25 women, 6 men) being lower than that for whites (P < .0001). The prevalence of PHPT tripled during the study period, increasing from 76 to 233 per 100,000 women and from 30 to 85 per 100 000 men. Racial differences in prevalence mirrored those found in incidence. CONCLUSIONS PHPT is the predominant cause of hypercalcemia and is increasingly prevalent. Substantial differences are found in the incidence and prevalence of PHPT between races.

[1]  Marcello Pagano,et al.  Principles of Biostatistics , 1992 .

[2]  J. Aloia.  African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. , 2008, The American journal of clinical nutrition.

[3]  P. Ituarte,et al.  Surgery for Primary Hyperparathyroidism: Are the Consensus Guidelines Being Followed? , 2012, Annals of surgery.

[4]  M. Nevitt,et al.  Defining physiologically “normal” vitamin D in African Americans , 2012, Osteoporosis International.

[5]  L. Rostomian,et al.  Epidemiology of primary hyperparathyroidism in Russia (the first results from the database of Federal state institution «Endocrinological Research Centre») , 2011 .

[6]  J. Manson,et al.  Serum 25‐hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: The women's health initiative (WHI) , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  J. Bilezikian,et al.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. , 2009, The Journal of clinical endocrinology and metabolism.

[8]  Sundeep Khosla,et al.  Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993–2001: An Update on the Changing Epidemiology of the Disease , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  I. Gough.  Surgery for asymptomatic primary hyperparathyroidism. , 1991, The Australian and New Zealand journal of surgery.

[10]  F. Lafferty,et al.  Differential diagnosis of hypercalcemia , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  D. Chen,et al.  The 25(OH)D/PTH threshold in black women. , 2010, The Journal of clinical endocrinology and metabolism.

[12]  E. Lukacz,et al.  Prevalence and Co-Occurrence of Pelvic Floor Disorders in Community-Dwelling Women , 2008, Obstetrics and gynecology.

[13]  J. Rastad,et al.  Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. , 2004, Surgery.

[14]  K. Hellström,et al.  Prevalence of hypercalcaemia in a health screening in Stockholm. , 2009, Acta medica Scandinavica.

[15]  F. Pattou,et al.  Parathyroid Incidentalomas in Normocalcemic Patients during Thyroid Surgery , 1996, World Journal of Surgery.

[16]  O. Clark,et al.  Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. , 2009, The Journal of clinical endocrinology and metabolism.

[17]  R. Rizzoli,et al.  Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. , 2009, Swiss medical weekly.

[18]  Sherita Hill Golden,et al.  Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. , 2012, The Journal of clinical endocrinology and metabolism.

[19]  Ning Yu,et al.  Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK , 2009, Clinical endocrinology.

[20]  R. Hamman,et al.  The SEARCH for Diabetes in Youth Study: Rationale, Findings, and Future Directions , 2014, Diabetes Care.

[21]  C. Marcocci,et al.  Epidemiology of primary hyperparathyroidism in Europe. , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  Dana Dabelea,et al.  Incidence of diabetes in youth in the United States. , 2007, JAMA.

[23]  P. Vestergaard,et al.  Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism , 2003, BMJ : British Medical Journal.

[24]  Hardeo Sahai,et al.  Confidence Intervals for the Mean of a Poisson Distribution: A Review , 1993 .

[25]  W. O'Fallon,et al.  The Rise and Fall of Primary Hyperparathyroidism: A Population-Based Study in Rochester, Minnesota, 1965-1992 , 1997, Annals of Internal Medicine.

[26]  R. Vassilopoulou-sellin,et al.  Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center , 1993, Cancer.